Ulcerative Colitis Clinical Trials near Cleveland, OH
15 studies for Ulcerative Colitis are recruiting at 18 sites within 50 miles of Cleveland, Ohio, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Cleveland.
Recruiting now
Ulcerative Colitis studies enrolling near Cleveland
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
NCT05287126
- Phase 2
- Ages 12 to 17 years
- Sex: All
Nearest sites: University Hospitals Cleveland Medical Center (Cleveland, OH); University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
NCT05076175
- Phase 2/3
- Ages 2 to 17 years
- Sex: All
Nearest site: Cleveland Clinic (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: University Hospitals Cleveland Medical Center /ID# 271831 (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
NCT07513181
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Cleveland Clinic Foundation (Cleveland, OH)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: NorthShore Gastroenterology Research, LLC (Westlake, OH); Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Site US-027 (Westlake, OH); Site US-025 (Brunswick, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
NCT06095128
- Phase 4
- Ages 18 to 65 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, LLC. (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT06398626
- Observational
- Ages 18 to 64 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, LLC (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
NCT06810518
- Observational
- Ages 22 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, LLC (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: North Shore Gastroenterology Research - Site Number: 8400130 (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07185009
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: North Shore Gastroenterology Research - Site Number: 8400130 (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio, LLC (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Gastro Intestinal Research Institute of Northern Ohio /ID# 283860 (Westlake, OH)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Great Lakes Gastroenterology Research, LLC (Mentor, OH)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Ulcerative Colitis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.